PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 14, 2026Chemical Reviews25 citations

Smallest Bicycles in Medicinal Chemistry: Where Are We Now?

View Full Paper
VKVladimir KubyshkinPMPavel K. Mykhailiuk

Key Points

  • The aim is to review the integration of small bicyclic and spirocyclic ring systems in medicinal chemistry and their applications in drug discovery.
  • Summarized advancements in bicyclic and spirocyclic systems as medicinal scaffolds.
  • Discussed molecular strains and geometry as bioisosteres for saturated benzene.
  • Examined synthesis approaches and current commercial availability of building blocks.
  • At least eight bicyclic structures have progressed to clinical trials, including vanzacaftor which received FDA approval.
  • Bicyclo[1.1.1]pentane and spiro[3.3]heptane are now common in medicinal chemistry, while other structures remain underexplored.
  • Identified knowledge gaps and encouraged focus on small saturated skeletons for future innovations.

Abstract

The replacement of aromatic rings with saturated molecular frameworks is a recent development encapsulated by the motto “escape from flatland” and conceptualized through the use of saturated benzene bioisosteres. This Review summarizes the application of the smallest bicyclic and spirocyclic ring systems as saturated scaffolds, focusing on applications in constructing bioactive molecules. We discuss considerations of their molecular strains, their potential to serve as saturated benzene isosteres in terms of both volume and geometry, and structural data derived from small-molecule and protein crystallography. Additionally, we present general approaches to synthesis, examine the current commercial availability of functional building blocks, and present existing examples of applications of bicyclic systems in drug discovery programs. At least eight structures based on the smallest skeletons have advanced to clinical trials, with one, vanzacaftor, recently receiving U.S. FDA approval. Our analysis indicates that small bicyclic fragments are represented exceptionally unevenly. While bicyclo1.1.1pentane and spiro3.3heptane have become routine and indispensable in medicinal chemistry over the past decade, ladderane and housane remain exotic and unexplored. We highlight knowledge gaps, aiming to stimulate interest in small saturated skeletons for innovative molecular engineering.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kubyshkin et al. (2026) studied this question.

synapsesocial.com/papers/69b4fbb1b39f7826a300c147https://doi.org/10.1021/acs.chemrev.5c00779
Ask AI
Helpful
Bookmark
Share
View Full Paper